Grace Therapeutics, Inc.
Grace Therapeutics is a late-stage biopharma company focused on rare and orphan diseases. Their lead drug candidate, GTx-104, is a novel injectable formulation for the treatment of aneurysmal subarachnoid hemorrhage (aSAH). The company holds Orphan Drug Designation by the FDA and has over 40 granted and pending patents.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
BRISTOL MYERS SQUIBB CO
Bristol Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines. Their key products and services include treatments for cancer, cardiovascular disease, immunology, and other serious diseases. BMS is positioned as a leading company in the pharmaceutical industry, with a commitment to research and development to improve patient outcomes.
AVADEL PHARMACEUTICALS PLC
Avadel is a biopharmaceutical company focused on transforming medicines to transform lives. They develop innovative solutions for medications that address the challenges patients face with current treatment options. Avadel is disrupting treatment paradigms where it's needed most, starting with narcolepsy.
Grifols SA
Since 1909, Grifols has worked to improve the health and well-being of people worldwide. They develop, produce, and market innovative medicines, solutions, and services in over 110 countries. Grifols is a global leader in biopharmaceuticals and diagnostics, with a focus on plasma-derived therapies. They are committed to innovation and sustainability.